Essential Bromodomain TcBDF2 as a Drug Target against Chagas Disease

Area of Science:

• Parasitology
• Molecular Biology
• Epigenetics

Background:

• Trypanosoma cruzi causes Chagas disease, a global health concern.
• Epigenetic mechanisms, including bromodomain proteins, regulate gene expression in trypanosomatids.
• Understanding these regulatory mechanisms is crucial for developing new therapeutic strategies.

Purpose of the Study:

• To investigate the function and essentiality of the TcBDF2 bromodomain protein in Trypanosoma cruzi.
• To explore TcBDF2's role in parasite infectivity, replication, and differentiation.
• To assess TcBDF2 as a potential drug target.

Main Methods:

• Utilized Tet-regulated overexpression and CRISPR/Cas9 genome editing in Trypanosoma cruzi.
• Investigated TcBDF2 localization within the parasite nucleus.
• Assessed the impact of TcBDF2 manipulation on parasite infectivity, replication, and differentiation stages.

Main Results:

• Demonstrated TcBDF2 is essential for Trypanosoma cruzi viability and nuclear localization.
• TcBDF2 is critical for host cell invasion, amastigote replication, and amastigote-to-trypomastigote differentiation.
• Overexpression of TcBDF2 inhibited epimastigote replication and altered pathogenesis-related processes.
• TcBDF2 exhibits distinct inhibitor binding specificity compared to TcBDF3.

Conclusions:

• TcBDF2 is an essential epigenetic regulator in Trypanosoma cruzi.
• TcBDF2 plays vital roles in parasite infectivity and lifecycle progression.
• TcBDF2 represents a promising and druggable therapeutic target for Chagas disease.